Most published information currently comes from: While many findings appear promising, additional research is needed to better understand long-term safety, effectiveness, dosing protocols, and potential risks in diverse patient populations
This concern comes out of observing a very small but nevertheless increased risk of thyroid cancer in rodents that was observed for another drug (liraglutide) that is in the same class as exenatide
Additional benefits of weight loss included reductions in blood pressure and waist circumference, these positive changes also reduced the risk of heart attacks and strokes
To view a copy of this licence, visit About this article Cite this article Dar, N.J., Soriano-Castell, D
Factors such as age, body mass, baseline hormone levels, and individual response to treatment can influence the necessary dosage of sermorelin